- +972 3 5666166
- cophy@comtecmed.com
Tell A Friend
Scientific Program
- Home
- Scientific Program
| FRIDAY, MARCH 27, 2020 | |
| 08:00-08:30 | OPENING CEREMONY |
| Chairs: | Neil Bressler, USA; Anat Loewenstein, Israel; José Cunha-Vaz, Portugal |
| 08:00-08:10 | Welcome to COPHy EU 2020: Neil Bressler, USA; Anat Loewenstein, Israel |
| 08:10-08:20 | Opening Remarks |
| 08:20-08:30 | EU 2020 Recipients of Global Ophthalmology Awards Program (GOAP)* Moderators: Francesco Bandello, Italy; Peter Kertes, Canada (*GOAP is awarded by an independent committee of eminent ophthalmology professionals – consistent with COPHy priorities to support research and education of young ophthalmologists, European awardees of GOAP awards are presented at annual COPHy meetings, with poster presentations of awardees.) |
| 08:30-10:00 | Big Controversies in Retina in 2020 |
| Chairs: | Neil Bressler, USA; Angela Carneiro, Portugal; Peter Kertes, Canada |
| 08:30-09:00 | Debate 1: Bevacizumab and Aflibercept and Ranibizumab are the Same for Macular Edema from Retinal Vein Occlusion (SCORE, LEAVO trial) |
| 08:30-08:40 | Yes: Angela Carneiro, Portugal |
| 08:40-08:50 | No: Usha Chakravarthy, UK |
| 08:50-09:00 | Discussion |
| 09:00-09:30 | Debate 2: Treat and Extend for Neovascular AMD is Preferred to PRN |
| 09:00-09:10 | Yes: Peter Kertes, Canada |
| 09:10-09:20 | No: Susan Bressler, USA |
| 09:20-09:30 | Discussion |
| 09:30-10:00 | Debate 3: Proliferative diabetic retinopathy: Five-year outcomes confirm anti-VEGF without PRP is an acceptable initial treatment |
| 09:30-09:40 | Yes: Barry Kuppermann, USA |
| 09:40-09:50 | No: Paolo Lanzetta, Italy |
| 09:50-10:00 | Discussion |
| 10:00-10:30 | Visit Exhibits & Coffee Break |
| 10:30-12:00 | MEDICAL RETINA 1 | Neovascular (‘Wet”) AMD Management |
| Chairs: | Susan Bressler, USA; Nicole Eter, Germany; Jordi Mones, Spain |
| 10:30-11:00 | Debate 1: Brolucizumab Represents an Improvement over Aflibercept |
| 10:30-10:40 | Yes: Francesco Bandello, Italy |
| 10:40-10:50 | No: Stela Vujosevic, Italy |
| 10:50-11:00 | Discussion |
| 11:00-11:30 | Debate 2: Neither OCT nor OCTA is Good Enough for Anti-VEGF Follow-up All of the Time – Fluorescein Angiography is Needed At Least 10% of the Time |
| 11:00-11:10 | Yes: Susan Bressler, USA |
| 11:10-11:20 | No: Angela Carneiro, Portugal |
| 11:20-11:30 | Discussion |
| 11:30-12:00 | Debate 3: Treatment of Non-exudative CNV should Begin when Detected on OCT Angiography, Even in the Absence of OCT Fluid or Fluorescein Leakage |
| 11:30-11:40 | Yes: Francesco Bandello, Italy |
| 11:40-11:50 | No: Patricia Udaondo, Spain |
| 11:50-12:00 | Discussion |
| 12:00-12:10 | Visit Exhibits & Lunch Box Pick-up |
| 12:10-13:25 | Industry-Sponsored Luncheon Symposium |
| 13:25-13:45 | Visit to Exhibition & Dessert Break |
| 13:45-15:00 | Vision Academy in Retina 2020 |
| Chairs: | Neil Bressler, USA; Anat Loewenstein, Israel |
| 13:45-13:55 | An introduction to the Vision Academy: Neil Bressler, USA |
| 13:55-14:10 | An overview of posters presented at COPHY EU from the European 2020 recipients of the Global Ophthalmology Awards Program (GOAP): Peter Kertes, Cananda |
| 14:10-14:30 | Debate I: Can Intravitreal Anti-VEGF Therapy be Used in Pregnant or Breastfeeding Patients? |
| 14:10-14:15 | For: Jean-Francois Korobelnik, France |
| 14:15-14:20 | Against: Paolo Lanzetta, Italy |
| 14:20-14:25 | Presentation of Viewpoint: Anat Loewenstein, Israel |
| 14:25-14:30 | Questions |
| 14:30-14:50 | Debate II: T&E Retreatment/Extension Decisions Should Differentiate Between Intraretinal and Subretinal Fluid in AMD |
| 14:30-14:35 | Yes: Nicole Eter, Germany |
| 14:35-14:40 | No: José Cunha-Vaz, Portugal |
| 14:40-14:45 | Presentation of Viewpoint: Anat Loewenstein, Israel |
| 14:45-14:50 | Questions |
| 14:50-15:00 | Looking forward with the Vision Academy: Anat Loewenstein, Israel |
| 15:00-15:30 | Visit Exhibits & Coffee Break |
| 15:30-17:00 | MEDICAL RETINA 2 | Diabetic Macular Edema (DME) |
| Chairs: | Luis Arias, Spain; José Cunha-Vaz, Portugal; Paolo Lanzetta, Italy |
| 15:30-16:00 | Debate 1: Corticosteroids are Warranted in the Management of Chronic DME |
| 15:30-15:40 | Yes: José Cunha-Vaz, Portugal |
| 15:40-15:50 | No: Susan Bressler, USA |
| 15:50-16:00 | Discussion |
| 16:00-16:30 | Debate 2: Vision or OCT Outcomes after Three Months Reliably Predict 2-Year Outcomes |
| 16:00-16:10 | Yes: Luis Arias, Spain |
| 16:10-16:20 | No: Paolo Lanzetta, Italy |
| 16:20-16:30 | Discussion |
| 16:30-17:00 | Debate 3: Ang2-inhibition Offers Long-Term Sustained Treatment Benefits For DME |
| 16:30-16:40 | Yes: Sandrine Zweifel, Switzerland |
| 16:40-16:50 | No: Patricia Udaondo, Spain |
| 16:50-17:00 | Discussion |
| 17:00-18:00 | Industry-Sponsored Symposium |
| SATURDAY, MARCH 28, 2020 | |
| 07:45-09:00 | Industry-Sponsored Symposium |
| 09:00-10:30 | MEDICAL RETINA 3 | Potentially Longer Acting Agents |
| Chairs: | Francesco Bandello, Italy; Usha Chakravarthy, UK; Stela Vujosevic, Italy |
| 09:00-09:30 | Debate 1: Port Deliver Systems Represents An Incremental Improvement in AMD |
| 09:00-09:10 | Yes: Eugene de Juan, USA |
| 09:10-09:20 | No: Stephan Michels, Switzerland |
| 09:20-09:30 | Discussion |
| 09:30-10:00 | Debate 2: Faricimab Represents An Improvement in DME |
| 09:30-09:40 | Yes: Jean-Francois Korobelnik, France |
| 09:40-09:50 | No: Stela Vujosevic, Italy |
| 09:50-10:00 | Discussion |
| 10:00-10:30 | Debate 3: Abicipar Represents an Improvement in the Treatment of AMD |
| 10:00-10:10 | Yes: Jean-Francois Korobelnik, France |
| 10:10-10:20 | No: Barry Kuppermann, USA |
| 10:20-10:30 | Discussion |
| 10:30-11:00 | Visit Exhibits & Coffee and Refreshment Break |
| 11:00-12:30 | MEDICAL RETINA 4 | AMD and Hereditary Retinal Degeneration Topics |
| Chairs: | Jean-Francois Korobelnik, France; Hendrik Scholl, Switzerland; Rufino Silva, Portugal |
| 11:00-11:30 | Debate 1: Gene Therapy is a Promising Strategy in in the Management of Non-Neovascular AMD |
| 11:00-11:10 | Yes: Jordi Mones, Spain |
| 11:10-11:20 | No: Hendrik Scholl, Switzerland |
| 11:20-11:30 | Discussion |
| 11:30-12:00 | Debate 2: Home Monitoring with OCT to Detect Onset of Choroidal Neovascularization will Improve Visual Acuity Outcomes |
| 11:30-11:40 | Yes: Jordi Mones, Spain |
| 11:40-11:50 | No: Rufino Silva, Portugal |
| 11:50-12:00 | Discussion |
| 12:00-12:30 | Debate 3: Genetic Testing for Clinical Care, Not Just Research, Sometimes is Warranted in Pattern Dystrophy Phenotypes |
| 12:00-12:10 | Yes: Hendrik Scholl, Switzerland |
| 12:10-12:20 | No: Stephan Michels, Switzerland |
| 12:20-12:30 | Discussion |
| 12:30-12:40 | Visit Exhibits & Lunch Box Pick-up |
| 12:40-14:00 | Industry-Sponsored Luncheon Symposium |
| 14:00-14:30 | Visit to Exhibition & Dessert Break |
| 14:30-16:00 | MEDICAL RETINA 5 | Imaging Controversies |
| Chairs: | Usha Chakravarthy, UK; Hendrik Scholl, Switzerland |
| 14:30-15:00 | Debate 1: OCT A Should be Obtained Routinely in Cases of Age-related Macular Degeneration |
| 14:30-14:40 | Yes: Sandrine Zweifel, Switzerland |
| 14:40-14:50 | No: Nicole Eter, Germany |
| 14:50-15:00 | Discussion |
| 15:00-15:30 | Debate 2: Ultra Wide Field Retinal Photography is Essential to Managing Diabetic Retinopathy |
| 15:00-15:10 | Yes: Usha Chakravarthy, UK |
| 15:10-15:20 | No: Rufino Silva, Portugal |
| 15:20-15:30 | Discussion |
| 15:30-16:00 | Debate 3: Autofluorescence Imaging, Not Fundus Photos or OCT, Should be Used to Monitor Geographic Atrophy |
| 15:30-15:40 | Yes: Hendrik Scholl, Switzerland |
| 15:40-15:50 | No: |
| 15:50-16:00 | Discussion |
| 16:00-17:30 | UVEITIS |
| Chairs: | Bahram Bodaghi, France; Zohar Habot-Wilner, Israel |
| 16:00-16:30 | Debate 1: Long Acting Intravitreal Corticosteroids for the Treatment of Noninfectious Posterior Segment Uveitis is Better than Systemic Treatment |
| 16:00-16:10 | Yes: Carlos Pavesio, England |
| 16:10-16:20 | No: Bahram Bodaghi, France |
| 16:20-16:30 | Discussion |
| 16:30-17:00 | Debate 2: Topical Prostaglandins May be Used in Uveitic Hypertension/Glaucoma |
| 16:30-16:40 | Yes: Zohar Habot-Wilner, Israel |
| 16:40-16:50 | No: Carlos Pavesio, England |
| 16:50-17:00 | Discussion |
| 17:00-17:30 | Debate 3: OCT-Angiography is a Must-Have Tool for the Management of White Dot Syndromes |
| 17:00-17:10 | Yes: Bahram Bodaghi, France |
| 17:10-17:20 | No: Zohar Habot-Wilner, Israel |
| 17:20-17:30 | Discussion |
| FRIDAY, MARCH 27, 2020 | |
| 10:30-12:00 | SURGICAL RETINA 1 | MACULAR HOLES |
| Chairs: | Stratos Gotzaridis, Greece; Joseph Moisseiev, Israel |
| 10:30-11:00 | Debate 1: Long Standing Macular Holes Should be Treated Surgically |
| 10:30-10:40 | Yes: Joseph Moisseiev, Israel |
| 10:40-10:50 | No: Stratos Gotzaridis, Greece |
| 10:50-11:00 | Discussion |
| 11:00-11:30 | Debate 2: Some Cases of VMT can be Treated by Intravitreal Air or Gas Injection |
| 11:00-11:10 | Yes: Stratos Gotzaridis, Greece |
| 11:10-11:20 | No: William Mieler, USA |
| 11:20-11:30 | Discussion |
| 11:30-12:00 | Debate 3: Vitrectomy for ERM with Clear Lens: Typically Do Lens Extraction Simultaneously |
| 11:30-11:40 | Yes: Barry Kuppermann, USA |
| 11:40-11:50 | No: Joseph Moisseiev, Israel |
| 11:50-12:00 | Discussion |
| 12:00-12:10 | Visit to Exhibition & Lunch Box Pick Up |
| 12:10-13:25 | Industry-sponsored Luncheon Symposium (Hall A) |
| 13:25-13:45 | Visit Exhibits & Dessert Break |
| 15:00-15:30 | Visit Exhibits & Coffee and Refreshment Break |
| 15:30-17:00 | GLAUCOMA |
| Chairs: | Francesca Cordeiro, UK; Tony Hommer, Austria |
| 15:30-16:00 | Debate 1: There is too much Dark in the LiGHT Study |
| 15:30-15:40 | Yes: Tony Hommer, Austria |
| 15:40-15:50 | No: |
| 15:50-16:00 | Discussion |
| 16:00-16:30 | Debate 2: The Trabecular Mesh Work is not a Viable target in Glaucoma |
| 16:00-16:10 | Yes: Joao Barbosa Breda, Portugal |
| 16:10-16:20 | No: |
| 16:20-16:30 | Discussion |
| 16:30-17:00 | Debate 3: AI has no Place in Glaucoma Practice |
| 16:30-16:40 | Yes: Francesca Cordeiro, UK |
| 16:40-16:50 | No: Joao Barbosa Breda, Portugal |
| 16:50-17:00 | Discussion |
| 17:00-18:00 | Industry-Sponsored Symposium (Hall A) |
| SATURDAY, MARCH 28, 2020 | |
| 07:45-09:00 | Industry-Sponsored Symposium (Hall A) |
| 09:00-10:30 | NEURO-OPHTHALMOLOGY 1 | The Afferent Pathway |
| Chairs: | Pedro Fonseca, Portugal; Neil Miller, USA |
| 09:00-09:30 | Debate 1: Patients with Acute Optic Neuritis Typically Should Have an Assay for Anti-Aquaporin-4 Antibodies, Anti-MOG Antibodies, or Both |
| 09:00-09:10 | Yes: Eduardo Silva, Portugal |
| 09:10-09:20 | No: Pedro Fonseca, Portugal |
| 09:20-09:30 | Discussion |
| 09:30-10:00 | Debate 2: Patients with “Typical" Acute Optic Neuritis Usually Should be Treated with IV Methylprednisolone |
| 09:30-09:40 | Yes: Neil Miller, USA |
| 09:40-09:50 | No: Dalia Meira, Portugal |
| 09:50-10:00 | Discussion |
| 10:00-10:30 | Case Presentations |
| Moderator: Neil Miller, USA | |
| Panelists: All Speakers | |
| 1. A Young Man with Loss of Vision After Blunt Head Trauma | |
| 2. A Young Man With Painless Bilateral Sequential Visual Loss | |
| 3. A Child With Decreased Vision | |
| 4. An Older Woman With Sudden Painless Visual Loss | |
| 5. An Older Man With Episodes Of Transient Monocular Visual Loss | |
| 10:30-11:00 | Visit to Exhibition & Coffee and Refreshment Break |
| 11:00-12:30 | TUMORS | Ocular Melanoma |
| Chairs: | Bertil Damato, UK; Mandeep Sagoo, UK |
| 11:00-11:30 | Debate 1: Monitoring of Melanocytic Chroidal Tumors is Dangerous |
| 11:00-11:10 | Yes: Bertil Damato, UK |
| 11:10-11:20 | No: |
| 11:20-11:30 | Discussion |
| 11:30-12:00 | Debate 2: Randomized Clinical Trials are Needed to Evaluate Intra-Arterial Chemotherapy for Retinoblastoma |
| 11:30-11:40 | Yes: |
| 11:40-11:50 | No: Mandeep Sagoo, UK |
| 11:50-12:00 | Discussion |
| 12:00-12:30 | Debate 3: Adjunctive Treatment for Conjunctival Carcinoma Should be Topical Interferon and not Topical 5-FU |
| 12:00-12:10 | Yes: Mandeep Sagoo, UK |
| 12:10-12:20 | No: Bertil Damato, UK |
| 12:20-12:30 | Discussion |
| 12:30-12:40 | Lunch Box Pick-Up |
| 12:40-14:00 | Industry-Sponsored Luncheon Symposium (Hall A) |
| 14:00-14:30 | Visit Exhibits & Desert Break |
| 14:30-16:00 | NEURO-OPHTHALMOLOGY 2 | The Efferent Pathway and Systemic Disorders |
| Chairs: | Dalia Meira, Portugal; Eduardo Silva, Portugal |
| 14:30-15:00 | Debate 1: A Patient With an Acute 6th Nerve Palsy Who is Over Age 50 and Who has Vascular Risk Factors Typically Requires Neuroimaging |
| 14:30-14:40 | Yes: Neil Miller, USA |
| 14:40-14:50 | No: Pedro Fonseca, Portugal |
| 14:50-15:00 | Discussion |
| 15:00-15:30 | Debate 2: A Temporal Artery Biopsy is Necessary in Almost Every Patient with Suspected Giant Cell Arteritis |
| 15:00-15:10 | Yes: Pedro Fonseca, Portugal |
| 15:10-15:20 | No: Dalia Meira, Portugal |
| 15:20-15:30 | Discussion |
| 15:30-16:00 | Case Presentations |
| Moderator: Neil Miller, USA | |
| Panelists: All Speakers | |
| 1. A Woman with Ptosis and Diplopia | |
| 2. A Man with Ptosis and Diplopia | |
| 3. A Child with Strabismus | |
| 4. A Child with Funny Eye Movements | |
| 5. A Elderly Man with Diplopia | |
| 16:00-17:30 | SURGICAL RETINA 2 | Surgical Systems |
| Chairs: | William Mieler, USA; Stanislao Rizzo, Italy |
| 16:00-16:30 | Debate 1: Voretigene Neparvovec-RZYL is a Viable Approach to Hereditary Retinal Degenerations |
| 16:00-16:10 | Yes: William Mieler, USA |
| 16:10-16:20 | No: Francesco Boscia, Italy |
| 16:20-16:30 | Discussion |
| 16:30-17:00 | Debate 2: 3D Monitors are Preferable to Surgical Microscope Systems |
| 16:30-16:40 | Yes: Stanislao Rizzo, Italy |
| 16:40-16:50 | No: William Mieler, USA |
| 16:50-17:00 | Discussion |
| 17:00-17:30 | Debate 3: Vitrectomy is Warranted for Worsening Myopic Macular Schisis in the Absence of Vitreomacular Traction |
| 17:00-17:10 | Yes: Stanislao Rizzo, Italy |
| 17:10-17:20 | No: Francesco Boscia, Italy |
| 17:20-17:30 | Discussion |